Methyl N-[4-[5-[[(1S)-2-fluoro-1-(3-methylphenyl)ethoxy]carbonylamino]-1-methyltriazol-4-yl]phenyl]carbamate
C21H22FN5O4 — CID 170050400
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[4-[5-[[(1S)-2-fluoro-1-(3-methylphenyl)ethoxy]carbonylamino]-1-methyltriazol-4-yl]phenyl]carbamate
Methyl N-[4-[5-[[(1S)-2-fluoro-1-(3-methylphenyl)ethoxy]carbonylamino]-1-methyltriazol-4-yl]phenyl]carbamate (PubChem CID 170050400) has the molecular formula C21H22FN5O4 and a molecular weight of 427.44 g/mol. Its IUPAC name is methyl N-[4-[5-[[(1S)-2-fluoro-1-(3-methylphenyl)ethoxy]carbonylamino]-1-methyltriazol-4-yl]phenyl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[4-[5-[[(1S)-2-fluoro-1-(3-methylphenyl)ethoxy]carbonylamino]-1-methyltriazol-4-yl]phenyl]carbamate |
|---|---|
| PubChem CID | 170050400 |
| Molecular Formula | C21H22FN5O4 |
| Molecular Weight | 427.44 g/mol |
| Exact Mass | 427.17 |
| IUPAC Name | methyl N-[4-[5-[[(1S)-2-fluoro-1-(3-methylphenyl)ethoxy]carbonylamino]-1-methyltriazol-4-yl]phenyl]carbamate |
| SMILES | COC(=O)Nc1ccc(-c2nnn(C)c2NC(=O)O[C@H](CF)c2cccc(C)c2)cc1 |
| InChI | InChI=1S/C21H22FN5O4/c1-13-5-4-6-15(11-13)17(12-22)31-21(29)24-19-18(25-26-27(19)2)14-7-9-16(10-8-14)23-20(28)30-3/h4-11,17H,12H2,1-3H3,(H,23,28)(H,24,29)/t17-/m1/s1 |
| InChIKey | WTJQEZBKQLDGEB-QGZVFWFLSA-N |
| XLogP | 4.23 |
| TPSA | 107.37 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.44 |
| LogP ≤ 5 | 4.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170050400 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.